tpLNP is Baiti Biotech's proprietary targeted lipid nanoparticle delivery platform, designed to deliver nucleic acid payloads such as CAR-encoding mRNA to specific immune cells. The company offers design, characterization and evaluation services.
| 平台定位 | 面向体内细胞治疗的靶向核酸递送 |
|---|---|
| 技术要素 | 靶向配体设计、LNP 配方、粒径/包封率表征 |
| 评价内容 | 递送效率、细胞选择性、表达水平与安全性相关指标 |
| 服务形式 | 平台技术服务与合作研究 |
与 LINCMECAR® 体内 CAR-T/M 技术体系配套使用;相关材料与制剂方向的发明专利已公开(专利状态以公开/授权区分为准)。
Sources: Baiti Biotech official site (www.100biotech.com), patent publications and ClinicalTrials.gov registrations. Updated 2026-11-21.
Baiti Biotech is an AI for Science medical research technology service company. It provides research technology services and collaborative research, not clinical treatment for patients.